| # | Drug | Count |
|---|---|---|
| 0 | DARUNAVIR | 2 |
| 1 | DARUNAVIR 600 MG | 2 |
| 2 | DARUNAVIR 800 MG | 2 |
| 3 | DICLOFENAC | 2 |
| 4 | DICLOFENAC SODIUM | 2 |
| 5 | DULOXETINE | 2 |
| 6 | DULOXETINE HYDROCHLORIDE | 2 |
| 7 | FLUOROURACIL | 2 |
| 8 | FLUOROURACIL CREAM, 0.5% | 2 |
| 9 | LAMIVUDINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RETIFANLIMAB-DLWR | 1 | 0.0139 |
| 1 | IBALIZUMAB | 1 | 0.0019 |
| 2 | SATRALIZUMAB | 1 | 0.0006 |
| 3 | EPOETIN ALFA-EPBX | 1 | 0.0004 |
| 4 | MARAVIROC | 1 | 0.0004 |
| 5 | RALTEGRAVIR | 2 | 0.0004 |
| 6 | DARUNAVIR 600 MG | 2 | 0.0003 |
| 7 | ALPROSTADIL | 1 | 0.0003 |
| 8 | FRUQUINTINIB | 1 | 0.0003 |
| 9 | ETRAVIRINE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 2 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 3 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Androgen [EPC] | 1 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |